CIK: 1952784 - Address: C/O Charles River Laboratories, 251 Ballardvale Street, Wilmington, MA 01887
7 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/4/24 16:09
2/29/24
CRLCharles River Laboratories International, Inc.HealthBiolabCommercial Physical & BiologiParisotto Shannon MMAOCEVP,DisS-960253.450-4-1034M
2/20/24 17:32
2/15/24
CRLCharles River Laboratories International, Inc.HealthBiolabCommercial Physical & BiologiParisotto Shannon MMAOCEVP,DisS.d-1,419241.210-6-1338D
2/20/24 17:32
2/15/24
CRLCharles River Laboratories International, Inc.HealthBiolabCommercial Physical & BiologiParisotto Shannon MMAOCEVP,DisM.d851144.67061838D
2/21/23 17:39
2/16/23
CRLCharles River Laboratories International, Inc.HealthBiolabCommercial Physical & BiologiParisotto Shannon MMAOCEVP,DisM.d498109.34051535D
2/21/23 17:39
2/16/23
CRLCharles River Laboratories International, Inc.HealthBiolabCommercial Physical & BiologiParisotto Shannon MMAOCEVP,DisS.d-1,160254.410-5-1235D
11/17/22 17:22
11/15/22
CRLCharles River Laboratories International, Inc.HealthBiolabCommercial Physical & BiologiParisotto Shannon MMAOCEVP,DisM.d249109.3402832D
11/17/22 17:22
11/15/22
CRLCharles River Laboratories International, Inc.HealthBiolabCommercial Physical & BiologiParisotto Shannon MMAOCEVP,DisS.d-570249.900-2-732D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact